Summary
The α1-adrenoceptor subtypes of dog prostate were characterized in binding and functional experiments. In saturation experiments, [3H]prazosin bound to α1-adrenoceptors with high affinity. In the displacement experiments, unlabelled prazosin and WB4101 biphasically inhibited the binding of 400 pM [3H]prazosin, suggesting the presence of at least two distinct affinity sites for prazosin or WB4101. The proportion of high-affinity sites was approximately 10%. HV723 also recognized two distinct affinity sites but the proportion of high-affinity sites was approximately 20%. From these results the presence of three distinct α1-adrenoceptor subtypes was suggested: presumably subtypes α1A (high affinity for prazosin and WB4101), α1N (high affinity for only HV723) and α1L (low affinity for the three antagonists) according to the recently proposed α1-adrenoceptor subclassification. The density of subtype α1L was much higher than that of subtypes α1A and α1N subtypes. In the functional experiments, prazosin, WB4101 and HV723 competitively antagonized the contractile response to noradrenaline with low affinities close to those estimated for the α1L subtypes. These results suggest that the contractile response to noradrenaline in the dog prostate is mediated predominantly through α1L subtype α-adrenoceptors.
Similar content being viewed by others
References
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
Bruchini H, Schmidt RA, Tanagho EA (1978) The male genitourinary sphincter mechanism in the dog. Invest Urol 15:284
Chapple CR, Aubry ML, James S, Greengrass PM, Burnstock G, Turner-Warwick RT, Milroy EJG, Davey MJ (1989) Characterization of human prostatic adrenoceptors using pharmacology receptor binding and localization. Br J Urol 63:487
Chapple CR, Burt RP, Marshall I (1991) 214-1 subtypes in the human prostate and inferior epigastric artery. Neurorol Urodyn 10:306
De Lean A, Hancock AA, Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21:5
Flavahn NA, Vanhoute PM (1986) α-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol Sci 7:347
Furuya S, Kumamoto Y, Yokoyama E, Tsukamoto T, Izumi T, Abiko Y, (1982) Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 128:83
Han C, Abel PW, Minneman KP (1987) α1-Adrenoceptor subtypes linked to different mechanism for increasing intracellular Ca2+ in smooth muscle. Nature 329:333
Hanft G, Gross G (1989) Subclassification of α1-adrenergic receptor recognition sites by urapidil derivative and selective antagonists. Br J Pharmacol 97:691
Hieble JP, Caine M, Zalaznik E (1985) In vitro characterization of the α-adrenoceptors in human prostate. Eur J Pharmacol 107:111
Hiramatsu Y, Muraoka R, Kigoshi S, Muramatsu I (1992) 5-Methylurapidil may discriminate between α1-adrenoceptors with a high affinity for WB4101 in rat lung. Br J Pharmacol 105:6
Kuru M (1965) Nervous control of micturation. Physiol Rev 45:425
MacGregor RJ, Diokno AC (1984) The alpha-adrenergic blocking action of prazosin hydrochloride on the canine urethra. Invest Urol 18:426
Molinoff PB, Wolfe BB, Weiland GA (1981) Quantitative analysis of drug-receptor interactions. II. Determination of the properties of receptor subtypes. Life Sci 29:427
Morita T (1991) Quantitative analyses of human prostatic α-adrenoceptors and effects of terazosin on the α-adrenoceptor activity. (abstract in English) J Smooth Muscle Res 27:149
Morrow AL, Creese I (1986) Characterization of α1-adrenergic receptor subtype in rat brain: a reevaluation of [3H]-WB4101 and [3H]-prazosin binding. Mol Pharmacol 29:321
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220
Muramatsu I, Kigoshi S, Ohmura T, Hashimoto S, Oshita M (1990) Pharmacological subclassification of α1-adrenoceptors in vascular smooth muscle. Br J Pharmacol 99:197
Muramatsu I, Kigoshi S, Ohmura T (1992) Subtypes of α1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn J Pharmacol 57:535
Ohmura T, Ohsita M, Kigoshi S, Muramatsu I (1992) Identification of α1-adrenoceptor subtypes in the rat vas deferens. Br J Pharmacol 107:697
Oshita M, Kigoshi S, Muramatsu I (1991) Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br J Pharmacol 104:961
Smith ER (1968) The stimulation of canine prostate secretion by parasympathomimetic agents. J Pharmacol Exp Ther 164:312
Wein AJ, Levin RM, Barrett DM (1987) Voiding function: relevant anatomy, physiology, and pharmacology. In: Gillenwater JY, Grayhack JT, Howards SS, Ducket JD (eds) Adult and pediatric urology. Year Book, Chicago, p 800
Yamada S, Ashizawa N, Ushizima H, Nakayama K, Hayashi E, Honda K (1987) Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy. J Pharmacol Exp Ther 242:326
Yamada S, Suzuki M, Kato Y, Kimura R, Mori R, Matsumoto K, Maruyama M, Kawabe K (1991) Binding characteristics of naftopidil and α-adrenoceptors in benign prostatic hypertrophy. Life Sci 50:127
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohmura, T., Sakamoto, S., Hayashi, H. et al. Identification of α1-adrenoceptor subtypes in the dog prostate. Urol. Res. 21, 211–215 (1993). https://doi.org/10.1007/BF00590038
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00590038